First human test of new drug begins
NCT ID NCT06310746
Summary
This was the first study in people to test the safety of a new drug called HLX6018. It involved 66 healthy volunteers who received a single dose to check for side effects and see how the drug moves through the body. The goal was to gather basic safety information before testing in patients with lung disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IPF are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Hospital of Jilin University
Changchun, Jilin, China
Conditions
Explore the condition pages connected to this study.